Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF. Atreya R, et al. Among authors: nishimoto n. Nat Med. 2000 May;6(5):583-8. doi: 10.1038/75068. Nat Med. 2000. PMID: 10802717
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.
Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, Neurath MF. Becker C, et al. Among authors: nishimoto n. Immunity. 2004 Oct;21(4):491-501. doi: 10.1016/j.immuni.2004.07.020. Immunity. 2004. PMID: 15485627 Free article.
The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.
Doganci A, Eigenbrod T, Krug N, De Sanctis GT, Hausding M, Erpenbeck VJ, Haddad el-B, Lehr HA, Schmitt E, Bopp T, Kallen KJ, Herz U, Schmitt S, Luft C, Hecht O, Hohlfeld JM, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Renz H, Neurath MF, Galle PR, Finotto S. Doganci A, et al. Among authors: nishimoto n. J Clin Invest. 2005 Feb;115(2):313-25. doi: 10.1172/JCI22433. J Clin Invest. 2005. PMID: 15668741 Free PMC article.
Interleukin 6: from bench to bedside.
Nishimoto N, Kishimoto T. Nishimoto N, et al. Nat Clin Pract Rheumatol. 2006 Nov;2(11):619-26. doi: 10.1038/ncprheum0338. Nat Clin Pract Rheumatol. 2006. PMID: 17075601 Review.
[Advances in interleukin-6 therapy].
Ogata A, Nishimoto N, Yoshizaki K. Ogata A, et al. Among authors: nishimoto n. Rinsho Byori. 1999 Apr;47(4):321-6. Rinsho Byori. 1999. PMID: 10340005 Review. Japanese.
Structure and function of a new STAT-induced STAT inhibitor.
Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. Naka T, et al. Among authors: nishimoto n. Nature. 1997 Jun 26;387(6636):924-9. doi: 10.1038/43219. Nature. 1997. PMID: 9202127
[Interleukin-6].
Nishimoto N, Ogata A, Shima Y, Yoshizaki K. Nishimoto N, et al. Gan To Kagaku Ryoho. 1994 Aug;21(10):1707-16. Gan To Kagaku Ryoho. 1994. PMID: 8060152 Review. Japanese.
361 results